Abbott ADC-75852 Libre View Healthcare Professionals User Guide

Abbott ADC-75852 Libre View Healthcare Professionals

Product Information: LibreView

LibreView is a software platform developed by Abbott that allows users to view and analyze glucose data collected from the FreeStyle Libre Flash Continuous Glucose Monitoring system. It is designed to help healthcare professionals and individuals with diabetes manage their glucose levels effectively. Please note that the patient data shown in this manual is for illustrative purposes only and does not represent actual patient data. For more detailed guidance on using LibreView, refer to the article “Practical Guidance for Using the FreeStyle Libre Flash Continuous Glucose Monitoring in Primary Care” by Jeff Unger,Pamela Kushner, and John E. Anderson (Postgraduate Medicine, May 2020). Important Safety Information can be found on the last page of this manual.

Product Usage Instructions

To incorporate LibreView into your practice and make the most out of its features, follow these steps:

1. Ensure that you have access to the FreeStyle Libre Flash Continuous Glucose Monitoring system. This system consists of a small sensor placed on the back of the upper arm and a reader or smartphone app to scan the sensor.
2. Collect glucose data using the FreeStyle Libre system as per the instructions provided with that product.
3. Connect the reader or smartphone app to your computer with internet access.
4. Visit the LibreView website (provide website URL) and sign in with your account credentials.
5. Follow the on-screen instructions to upload the glucose data from the reader or smartphone app to LibreView.
6. Once the data is uploaded, you can view and analyze it using various tools and features provided by LibreView.
7. Utilize the insights gained from the glucose data to make informed decisions regarding diabetes management and treatment.

For any technical issues or further assistance, refer to the user manual provided with the FreeStyle Libre Flash Continuous Glucose Monitoring system or contact Abbott customer support.

• The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice. †The user’s device must have internet connectivity for glucose data to automatically upload to LibreView. ‡Glucose readings are not available during 1-hour warm-up, when sensor is too hot or too cold, when you see an error or “LO” or “HI” message, or no current glucose reading.
• Unger, Jeff, Pamela Kushner, and John E. Anderson. “Practical Guidance for Using the FreeStyle Libre Flash Continuous Glucose Monitoring in Primary Care.” Postgraduate Medicine 132, no. 4 (May 2020): 305-313. https://doi.org/10.1080/00325481.2020.1744393.

See last page for Important Safety Information.

**Follow these steps to get the most out of LibreView***

95251: Analysis, interpretation, and reporting of CGM data for a minimum of 72 hours of data collection⁵
95249: Ambulatory CGM of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; patient-provided equipment, sensor placement, hook-up, calibration of monitor, patient training and printout of recording5

Practice these steps with the LibreView* reports available to you.

Note: Abbott provides this information as a courtesy, it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.
The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice. †Default range is 70-180 mg/dL. ‡For adults with type 1 and type 2 diabetes who are not pregnant, not older, or at risk. §The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.

1. ADA. Diabetes Care (2023): https://doi.org/10.2337/dc23-S006.

2. ADCES (2020). Accessed August 2023.
   https://www.diabeteseducator.org/docs/default-source/practice/educator-tools /cgm-playbooks/personal-cgm-playbook.pdf.

3. Bergenstal, R. M. ADA Clinical Compendia (2018): https://doi.org/10.2337/db20181-20.

4. Aleppo, G. Journal of Diabetes Science and Technology (2018): https://doi.org/10.1177/1932296818813581.

5. American Medical Association CPT. Professional Codebook (2023).

Using the Ambulatory Glucose Profile report

Mirroring the recommendations of the International Consensus1, the Ambulatory Glucose Profile (AGP) report report reveals glucose variations that can help focus treatment1,2

Not actual patient data; for illustrative purposes only.

Make more informed decisions with individualized data not reflected by A1c1, with the AGP report.
Default range is 70-180 mg/dL.
The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

1. Battelino, T. Diabetes Care (2019): https://doi.org/10.2337/dci19-0028.
2. ADA. Diabetes Care (2023): https://doi.org/10.2337/dc23-S006.
3. Vigersky, R. Diabetes Technology and Therapeutics (2019): https://doi.org/10.1089/dia.2018.0310.
4. Bergenstal, R. M. ADA Clinical Compendia (2018): https://doi.org/10.2337/db20181-20.

See last page for Important Safety Information.

Using the Glucose Pattern Insights report

The Glucose Pattern Insights (GPI) report provides a guided interpretation of your patient’s CGM data to highlight important patterns

Use the GPI report to elevate patient care and interpret CGM data.
Default range is 70-180 mg/dL.
The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

1. Battelino, T. Diabetes Care (2019): https://doi.org/10.2337/dci19-0028.
2. ADA. Diabetes Care (2023): https://doi.org/10.2337/dc23-S006.

See last page for Important Safety Information.

Assessing additional reports

Using patient-specific data, LibreView* reports uncover hidden glucose patterns for a complete picture1

SNAPSHOT
An overview of your patient’s average glucose and hypoglycemia events.

DAILY LOG
Entries for each time the patient scanned/viewed their glucose, performed a blood glucose test, and entered carbohydrates, insulin, and exercise.

WEEKLY SUMMARY
Shows average glucose, scans/views, carbs, and insulin entered for a full week.

Additional reports include:
Monthly Summary
Monthly list of daily average glucose readings, glucose scans/views per day, and low glucose events.

Mealtime Patterns
Highlights pre- and post-meal glucose levels throughout the day and daily averages for the 14-day wear period.

Daily Patterns
Shows glucose, carbohydrate, and insulin data over the “typical” day. Not actual patient data; for illustrative purposes only.

*Use different LibreView reports to tailor your discussions to your patient’s needs.**
The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

1. Unger, Jeff, Pamela Kushner, and John E. Anderson. “Practical Guidance for Using the FreeStyle Libre Flash Continuous Glucose Monitoring in Primary Care.” Postgraduate Medicine 132, no. 4 (May 2020): 305-313. https://doi.org/10.1080/00325481.2020.1744393.

See last page for Important Safety Information.

Getting started is easy with LibreView*

Visit LibreView.com/auth/register and follow these 3 steps or scan the QR code:

1. Set up a LibreView* Practice account
2. Add Care Team members
3. Choose an option to connect with patients to share data

You can do this in 2 ways:
Option 1: Share Practice ID
Write your ID in the box to share with your patients
Customize your Practice ID with something memorable (e.g., consider using a phone number, name of practice,or the last name of a provider for your Practice ID)

Option 2: Invite new or existing patients
Add their email to your LibreView* Practice through the patient dashboard

*Make the most of LibreView data and reports today!
Call
Toll Free:** 855-450-3563 ext 3, Monday-Friday 9:00am – 8:00pm ET

LibreView Specialist Team
Email
libreviewsupport@abbott.com

Book
1:1 session with the LibreView Specialist Team via their Team Booking Site – diabetescare.abbott/lvs

LibreView
The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice. The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.

IMPORTANT SAFETY INFORMATION
FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or https://www.freestyle.abbott/us-en/safety-information.html for safety info. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are property of their respective owners.
© 2023 Abbott. ADC-75852 v2.0 08/23

References

• LibreView Implementations
• LibreView
• 6. Glycemic Targets: Standards of Care in Diabetes—2023 | Diabetes Care | American Diabetes Association
• Understanding Continuous Glucose Monitoring Data | Compendia | American Diabetes Association
• 6. Glycemic Targets: Standards of Care in Diabetes—2023 | Diabetes Care | American Diabetes Association
• Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range | Diabetes Care | American Diabetes Association
• Safety Information | The FreeStyle Libre System

Read User Manual Online (PDF format)

Download This Manual (PDF format)

Download this manual  >>